Differential Expression of Thrombospondin (THBS1) in Tumorigenic and Nontumorigenic Prostate Epithelial Cells in Response to a Chromatin-binding Soy Peptide

Overview

Journal Nutr Cancer

Publisher Routledge

Specialties Nutritional Sciences
Oncology

Date 2011 Apr 29

PMID 21526452

Citations 11

Authors

Alfredo F Galvez

Liping Huang

Mark M J Magbanua

Kevin Dawson

Raymond L Rodriguez

Affiliations

Soon will be listed here.

Abstract

The chemopreventive properties of the chromatin-binding soy peptide, lunasin, are well documented, but its mechanism of action is unclear. To elucidate the mechanism by which lunasin reduces tumor foci formation in cultured mammalian cells, nontumorigenic (RWPE-1) and tumorigenic (RWPE-2) human prostate epithelial cells were treated with lunasin followed by gene expression profiling and characterization of the chromatin acetylation status for certain chemopreventive genes. The genes HIF1A, PRKAR1A, TOB1, and THBS1 were upregulated by lunasin in RWPE-1 but not in RWPE-2 cells. Using histone acetyltransferase (HAT) assays with acid-extracted histones as templates, we showed that lunasin specifically inhibited H4K8 acetylation while enhanced H4K16 acetylation catalyzed by HAT enzymes p300, PCAF, and HAT1A. These results suggest a novel mechanism for lunasin-dependent upregulation of gene expression. Chromatin immunoprecipitation (ChIP) revealed hypoacetylation of H4K16 in RWPE-2 cells, specifically at the 5' end of THBS1 containing a CpG island. Moreover, bisulfite PCR (BSP) and subsequent DNA sequencing indicated that this CpG island was hypomethylated in RWPE-1 but hypermethylated in RWPE-2 cells. Histone hypoacetylation and DNA hypermethylation in the 5' region of THBS1 may explain the inability of lunasin to upregulate this gene in RWPE-2 cells.

Citing Articles

Acetyl-CoA: An interplay between metabolism and epigenetics in cancer.

Hao Y, Yi Q, XiaoWu X, WeiBo C, GuangChen Z, XueMin C Front Mol Med. 2024; 2:1044585.

PMID: 39086974 PMC: 11285595. DOI: 10.3389/fmmed.2022.1044585.

Lunasin and Its Epigenetic Impact in Cancer Chemoprevention.

Kaufman-Szymczyk A, Kaczmarek W, Fabianowska-Majewska K, Lubecka-Gajewska K Int J Mol Sci. 2023; 24(11).

PMID: 37298139 PMC: 10253126. DOI: 10.3390/ijms24119187.

Cromolyn prevents cerebral vasospasm and dementia by targeting WDR43.

Wang X, Kong F, Lin Z Front Aging Neurosci. 2023; 15:1132733.

PMID: 37122373 PMC: 10133528. DOI: 10.3389/fnagi.2023.1132733.

Lunasin as a Promising Plant-Derived Peptide for Cancer Therapy.

Alves de Souza S, Hernandez-Ledesma B, Ferraz de Souza T Int J Mol Sci. 2022; 23(17).

PMID: 36076946 PMC: 9455814. DOI: 10.3390/ijms23179548.

Aureobasidium pullulans produced β-glucan is effective to enhance Kurosengoku soybean extract induced Thrombospondin-1 expression.

Muramatsu D, Okabe M, Takaoka A, Kida H, Iwai A Sci Rep. 2017; 7(1):2831.

PMID: 28588201 PMC: 5460285. DOI: 10.1038/s41598-017-03053-9.

References

Jeong H, Park J, Lam Y, de Lumen B . Characterization of lunasin isolated from soybean. J Agric Food Chem. 2003; 51(27):7901-6. DOI: 10.1021/jf034460y. View

Irizarry R, Hobbs B, Collin F, Beazer-Barclay Y, Antonellis K, Scherf U . Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003; 4(2):249-64. DOI: 10.1093/biostatistics/4.2.249. View

Lam Y, Galvez A, de Lumen B . Lunasin suppresses E1A-mediated transformation of mammalian cells but does not inhibit growth of immortalized and established cancer cell lines. Nutr Cancer. 2004; 47(1):88-94. DOI: 10.1207/s15327914nc4701_11. View

Ferrari R, Pellegrini M, Horwitz G, Xie W, Berk A, Kurdistani S . Epigenetic reprogramming by adenovirus e1a. Science. 2008; 321(5892):1086-8. PMC: 2693122. DOI: 10.1126/science.1155546. View

Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C . Epigenetic stem cell signature in cancer. Nat Genet. 2007; 39(2):157-8. DOI: 10.1038/ng1941. View

Jeong H, Lam Y, de Lumen B . Barley lunasin suppresses ras-induced colony formation and inhibits core histone acetylation in mammalian cells. J Agric Food Chem. 2002; 50(21):5903-8. DOI: 10.1021/jf0256945. View

Marmorstein R, Berger S . Structure and function of bromodomains in chromatin-regulating complexes. Gene. 2001; 272(1-2):1-9. DOI: 10.1016/s0378-1119(01)00519-4. View

Varier R, Swaminathan V, Balasubramanyam K, Kundu T . Implications of small molecule activators and inhibitors of histone acetyltransferases in chromatin therapy. Biochem Pharmacol. 2004; 68(6):1215-20. DOI: 10.1016/j.bcp.2004.05.038. View

Zeng L, Zhang Q, Gerona-Navarro G, Moshkina N, Zhou M . Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300. Structure. 2008; 16(4):643-52. PMC: 3339198. DOI: 10.1016/j.str.2008.01.010. View

10.

Seligson D, Horvath S, Shi T, Yu H, Tze S, Grunstein M . Global histone modification patterns predict risk of prostate cancer recurrence. Nature. 2005; 435(7046):1262-6. DOI: 10.1038/nature03672. View

11.

Timp W, Levchenko A, Feinberg A . A new link between epigenetic progenitor lesions in cancer and the dynamics of signal transduction. Cell Cycle. 2009; 8(3):383-90. PMC: 6275123. DOI: 10.4161/cc.8.3.7542. View

12.

Sobel R, Cook R, Perry C, Annunziato A, Allis C . Conservation of deposition-related acetylation sites in newly synthesized histones H3 and H4. Proc Natl Acad Sci U S A. 1995; 92(4):1237-41. PMC: 42674. DOI: 10.1073/pnas.92.4.1237. View

13.

Seo S, McNamara P, Heo S, Turner A, Lane W, Chakravarti D . Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell. 2001; 104(1):119-30. DOI: 10.1016/s0092-8674(01)00196-9. View

14.

Kuo M, Brownell J, Sobel R, Ranalli T, Cook R, Edmondson D . Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines. Nature. 1996; 383(6597):269-72. DOI: 10.1038/383269a0. View

15.

Rozen S, Skaletsky H . Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 1999; 132:365-86. DOI: 10.1385/1-59259-192-2:365. View

16.

Fraga M, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G . Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet. 2005; 37(4):391-400. DOI: 10.1038/ng1531. View

17.

Ferrari R, Berk A, Kurdistani S . Viral manipulation of the host epigenome for oncogenic transformation. Nat Rev Genet. 2009; 10(5):290-4. PMC: 2692573. DOI: 10.1038/nrg2539. View

18.

Cheung E, Wadhera P, Dorff T, Pinski J . Diet and prostate cancer risk reduction. Expert Rev Anticancer Ther. 2007; 8(1):43-50. DOI: 10.1586/14737140.8.1.43. View

19.

Hsieh C, Hernandez-Ledesma B, Jeong H, Park J, de Lumen B . Complementary roles in cancer prevention: protease inhibitor makes the cancer preventive peptide lunasin bioavailable. PLoS One. 2010; 5(1):e8890. PMC: 2811193. DOI: 10.1371/journal.pone.0008890. View

20.

Schiltz R, Mizzen C, Vassilev A, Cook R, Allis C, Nakatani Y . Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J Biol Chem. 1999; 274(3):1189-92. DOI: 10.1074/jbc.274.3.1189. View